A new treatment that can successfully reduce sensitivity to peanuts has been described as a 'game changer'.
It comes after the world's largest peanut allergy treatment trial, involving more than 60 Irish people.
Researchers believe these findings will provide a real lifeline to those affected by the most common food allergy, and the single cause of most food allergy deaths.
The immunotherapy trial will be submitted to the US Food and Drug Administration for a Biologics Licence Application by the end of the year.
Professor of Paediatrics and Child Health at UCC Jonathan Hourihane who was involved in the study says 'What we've been able to show is that by giving people small and increasing amounts of peanut over 4-6 months and then leaving them on a stable dose for 6 months, we were able to change their sensitivity to peanut from being only just about to be able to tolerate a 20th of a peanut to being able to tolerate 2 or 3 peanuts'.